News
12.08.2025
HKUMed, SMART and GBAICTI Met in Hong Kong to Foster Talent Exchange and Collaboration
On August 12, 2025, Prof. Bernard Cheung, CEO of GBAICTI, and Prof. CS Lau, Dean of HKUMed, met in Hong Kong with Prof. Nieng Yan, Founding President of Shenzhen Medical Academy of Research and Translation (SMART).
31.07.2025
GBAICTI Engaged With About 100 Industry Representatives to Enhance Hong Kong's Clinical Research Development
At a sharing session hosted by the Hospital Authority, the Greater Bay Area International Clinical Trial Institute (GBAICTI) engaged in-depth with around 100 industry representatives from over 30 companies to discuss enhancement measures and the future development of clinical trials in Hong Kong.
29.07.2025
GBAICTI, Bay Trial and Immuno Cure Signed Tripartite MOU to Strengthen GBA Clinical Research Collaboration
Greater Bay Area International Clinical Trial Institute, Greater Bay Area International Clinical Trials Center of Shenzhen and Immuno Cure BioTech signed a tripartite Memorandum of Understanding on July 29, 2025.
29.07.2025
GBAICTI and Bay Trial Signed a MOU to Strengthen Clinical Research Collaboration
GBAICTI and Bay Trial signed a Memorandum of Understanding on July 29, 2025 to strengthen collaboration between Shenzhen and Hong Kong in the field of clinical research.
09.07.2025
GBAICTI and Hong Kong Genome Institute Explore Partnership in Genomic Medicine
Greater Bay Area International Clinical Trial Institute (GBAICTI) met with Hong Kong Genome Institute (HKGI) to explore collaborative opportunities in genomic medicine.
26.06.2025
Delegation Visit of NMPA GBA Center
On June 26, 2025, a delegation from the GBA Center for Medical Device Evaluation and Inspection of the National Medical Products Administration (NMPA) visited GBAICTI to learn about the its facility, ongoing work, and future development plans.